EE200300586A - Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks - Google Patents
Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviksInfo
- Publication number
- EE200300586A EE200300586A EEP200300586A EEP200300586A EE200300586A EE 200300586 A EE200300586 A EE 200300586A EE P200300586 A EEP200300586 A EE P200300586A EE P200300586 A EEP200300586 A EE P200300586A EE 200300586 A EE200300586 A EE 200300586A
- Authority
- EE
- Estonia
- Prior art keywords
- adenosine
- treatment
- combination
- receptor agonist
- anticholinergic agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29384201P | 2001-05-25 | 2001-05-25 | |
GB0129275A GB0129275D0 (en) | 2001-12-06 | 2001-12-06 | Pharmaceutical combination |
GB0210238A GB0210238D0 (en) | 2002-05-03 | 2002-05-03 | Pharmaceutical composition |
PCT/EP2002/005725 WO2002096462A1 (en) | 2001-05-25 | 2002-05-24 | An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
EE200300586A true EE200300586A (et) | 2004-04-15 |
Family
ID=27256345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300586A EE200300586A (et) | 2001-05-25 | 2002-05-24 | Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks |
Country Status (22)
Country | Link |
---|---|
US (1) | US20040171576A1 (xx) |
EP (1) | EP1395287A1 (xx) |
KR (1) | KR20030097901A (xx) |
CN (1) | CN1535161A (xx) |
AP (1) | AP2003002911A0 (xx) |
BG (1) | BG108383A (xx) |
BR (1) | BR0209986A (xx) |
CA (1) | CA2448086A1 (xx) |
CO (1) | CO5540324A2 (xx) |
CZ (1) | CZ20033126A3 (xx) |
EE (1) | EE200300586A (xx) |
HU (1) | HUP0400029A2 (xx) |
IL (1) | IL158774A0 (xx) |
MA (1) | MA27028A1 (xx) |
MX (1) | MXPA03010787A (xx) |
NO (1) | NO20035202D0 (xx) |
OA (1) | OA12609A (xx) |
PA (1) | PA8546101A1 (xx) |
PL (1) | PL366899A1 (xx) |
SK (1) | SK14302003A3 (xx) |
SV (1) | SV2003001055A (xx) |
WO (1) | WO2002096462A1 (xx) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7427606B2 (en) * | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
AU2002362443B2 (en) | 2001-10-01 | 2008-05-15 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof |
GB0129273D0 (en) | 2001-12-06 | 2002-01-23 | Pfizer Ltd | Crystalline drug form |
TW200519106A (en) | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
GB0401334D0 (en) | 2004-01-21 | 2004-02-25 | Novartis Ag | Organic compounds |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
US7442687B2 (en) | 2004-08-02 | 2008-10-28 | The University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
EP2266994B1 (en) | 2004-08-02 | 2013-04-03 | University Of Virginia Patent Foundation | 2-propynyl adenosine analgos with modified 5'-ribose groups having A2A agonist activity |
GB0424284D0 (en) | 2004-11-02 | 2004-12-01 | Novartis Ag | Organic compounds |
GB0426164D0 (en) | 2004-11-29 | 2004-12-29 | Novartis Ag | Organic compounds |
GB0510390D0 (en) | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
GB0511065D0 (en) * | 2005-05-31 | 2005-07-06 | Novartis Ag | Organic compounds |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
EP2532679B1 (en) | 2005-10-21 | 2017-04-12 | Novartis AG | Human antibodies against il13 and therapeutic uses |
GB0601951D0 (en) | 2006-01-31 | 2006-03-15 | Novartis Ag | Organic compounds |
ATE502943T1 (de) | 2006-09-29 | 2011-04-15 | Novartis Ag | Pyrazolopyrimidine als pi3k-lipidkinasehemmer |
KR20090075714A (ko) | 2006-10-30 | 2009-07-08 | 노파르티스 아게 | 소염제로서의 헤테로시클릭 화합물 |
WO2009087224A1 (en) | 2008-01-11 | 2009-07-16 | Novartis Ag | Pyrimidines as kinase inhibitors |
TW201031406A (en) | 2009-01-29 | 2010-09-01 | Novartis Ag | Substituted benzimidazoles for the treatment of astrocytomas |
US8389526B2 (en) | 2009-08-07 | 2013-03-05 | Novartis Ag | 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives |
MX2012001838A (es) | 2009-08-12 | 2012-02-29 | Novartis Ag | Compuestos de hidrazona heterociclico y sus usos para tratar cancer e inflamacion. |
MY162604A (en) | 2009-08-17 | 2017-06-30 | Intellikine Llc | Heterocyclic compounds and uses thereof |
IN2012DN01453A (xx) | 2009-08-20 | 2015-06-05 | Novartis Ag | |
WO2012034095A1 (en) | 2010-09-09 | 2012-03-15 | Irm Llc | Compounds and compositions as trk inhibitors |
UY33597A (es) | 2010-09-09 | 2012-04-30 | Irm Llc | Compuestos y composiciones como inhibidores de la trk |
EP2673277A1 (en) | 2011-02-10 | 2013-12-18 | Novartis AG | [1, 2, 4]triazolo [4, 3 -b]pyridazine compounds as inhibitors of the c-met tyrosine kinase |
US9127000B2 (en) | 2011-02-23 | 2015-09-08 | Intellikine, LLC. | Heterocyclic compounds and uses thereof |
WO2012116217A1 (en) | 2011-02-25 | 2012-08-30 | Irm Llc | Compounds and compositions as trk inhibitors |
EP2755976B1 (en) | 2011-09-15 | 2018-07-18 | Novartis AG | 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyridines as c-met tyrosine kinase inhibitors |
EP2793893A4 (en) | 2011-11-23 | 2015-07-08 | Intellikine Llc | IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS |
CN104245701A (zh) | 2012-04-03 | 2014-12-24 | 诺华有限公司 | 有酪氨酸激酶抑制剂的组合产品和其应用 |
WO2014151147A1 (en) | 2013-03-15 | 2014-09-25 | Intellikine, Llc | Combination of kinase inhibitors and uses thereof |
TW201605450A (zh) | 2013-12-03 | 2016-02-16 | 諾華公司 | Mdm2抑制劑與BRAF抑制劑之組合及其用途 |
WO2016011658A1 (en) | 2014-07-25 | 2016-01-28 | Novartis Ag | Combination therapy |
AU2015294889B2 (en) | 2014-07-31 | 2018-03-15 | Novartis Ag | Combination therapy |
TW202140550A (zh) | 2020-01-29 | 2021-11-01 | 瑞士商諾華公司 | 使用抗tslp抗體治療炎性或阻塞性氣道疾病之方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL104068A (en) * | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
BR9914526A (pt) * | 1998-10-16 | 2001-07-03 | Pfizer | Derivados de adenina |
GB9924363D0 (en) * | 1999-10-14 | 1999-12-15 | Pfizer Central Res | Purine derivatives |
-
2002
- 2002-05-24 AP APAP/P/2003/002911A patent/AP2003002911A0/en unknown
- 2002-05-24 SK SK1430-2003A patent/SK14302003A3/sk not_active Application Discontinuation
- 2002-05-24 SV SV2002001055A patent/SV2003001055A/es not_active Application Discontinuation
- 2002-05-24 CA CA002448086A patent/CA2448086A1/en not_active Abandoned
- 2002-05-24 KR KR10-2003-7015411A patent/KR20030097901A/ko not_active Application Discontinuation
- 2002-05-24 MX MXPA03010787A patent/MXPA03010787A/es unknown
- 2002-05-24 PA PA20028546101A patent/PA8546101A1/es unknown
- 2002-05-24 OA OA1200300303A patent/OA12609A/en unknown
- 2002-05-24 BR BR0209986-1A patent/BR0209986A/pt not_active IP Right Cessation
- 2002-05-24 IL IL15877402A patent/IL158774A0/xx unknown
- 2002-05-24 EE EEP200300586A patent/EE200300586A/xx unknown
- 2002-05-24 HU HU0400029A patent/HUP0400029A2/hu unknown
- 2002-05-24 US US10/479,085 patent/US20040171576A1/en not_active Abandoned
- 2002-05-24 EP EP02745316A patent/EP1395287A1/en not_active Withdrawn
- 2002-05-24 CN CNA028106180A patent/CN1535161A/zh active Pending
- 2002-05-24 CZ CZ20033126A patent/CZ20033126A3/cs unknown
- 2002-05-24 PL PL02366899A patent/PL366899A1/xx unknown
- 2002-05-24 WO PCT/EP2002/005725 patent/WO2002096462A1/en not_active Application Discontinuation
-
2003
- 2003-11-18 CO CO03101662A patent/CO5540324A2/es not_active Application Discontinuation
- 2003-11-20 MA MA27409A patent/MA27028A1/fr unknown
- 2003-11-24 BG BG108383A patent/BG108383A/bg unknown
- 2003-11-24 NO NO20035202A patent/NO20035202D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ20033126A3 (cs) | 2004-09-15 |
US20040171576A1 (en) | 2004-09-02 |
PA8546101A1 (es) | 2003-12-10 |
AP2003002911A0 (en) | 2003-12-31 |
IL158774A0 (en) | 2004-05-12 |
CO5540324A2 (es) | 2005-07-29 |
OA12609A (en) | 2006-06-09 |
SV2003001055A (es) | 2003-11-14 |
CA2448086A1 (en) | 2002-12-05 |
NO20035202D0 (no) | 2003-11-24 |
MXPA03010787A (es) | 2004-03-02 |
SK14302003A3 (sk) | 2004-08-03 |
KR20030097901A (ko) | 2003-12-31 |
BR0209986A (pt) | 2004-04-06 |
MA27028A1 (fr) | 2004-12-20 |
WO2002096462A1 (en) | 2002-12-05 |
BG108383A (bg) | 2004-08-31 |
CN1535161A (zh) | 2004-10-06 |
PL366899A1 (en) | 2005-02-07 |
EP1395287A1 (en) | 2004-03-10 |
HUP0400029A2 (hu) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200300586A (et) | Adenosiini A2A retseptori agonisti ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks | |
EE200300585A (et) | PDE4 inhibiitori ja antikolinergilise vahendi kombinatsioon obstruktiivsete hingamisteede haiguste raviks | |
DK1041990T3 (da) | Præparat til behandling af respiratoriske sygdomme og hudsygdomme med mindst en leukotrien-antagonist og mindst et antihistamin | |
ZA200503645B (en) | Treatment of diseases with combinations of alpha 7 nicotinic acetylcholine receptor agonists and other compounds | |
IL164784A0 (en) | Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases | |
EE05516B1 (et) | Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine | |
ITMI20000312A0 (it) | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva | |
AU2002314110A1 (en) | Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways | |
EE05585B1 (et) | Indasoolihendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ning nende kasutamine | |
IL172564A0 (en) | N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF THE 5HT2c RECEPTOR ASSOCIATED DISEASES | |
HUP0401987A3 (en) | Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments | |
AU2003223579A8 (en) | Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease | |
PL373912A1 (en) | Heterocyclic derivatives for the treatment of cancer and other proliferative diseases | |
EE200300473A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
NO20041214L (no) | Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer | |
EE200300474A (et) | Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks | |
NO326689B1 (no) | Pyrrolidinderivater, anvendelse derav, farmasøytisk preparat samt fremgangsmåte for fremstilling av forbindelsene | |
IL198759A (en) | Use of 3gal receptor antagonists to prepare medications to treat depression and / or anxiety | |
EE200300328A (et) | IL-18 inhibiitorite kasutamine südamehaiguse raviks ja/või ennetamiseks | |
ITMI20010957A0 (it) | Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche | |
HUP0102388A3 (en) | Use of diazepinoindole derivatives for the preparation of pharmaceutical composition treating chronic obstructive pulmonary disease | |
PL375564A1 (en) | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma | |
NO20034561D0 (no) | Anvendelse av kationiske dekstranderivater for beskyttelse av dosebegrensende organer | |
NO20083239L (no) | Anvendelse av adenosin A2A reseptor agonist for fremstilling av et topisk medikament for å akselerere helingen av et sår | |
EE200300454A (et) | Bitsüklilised guanidiini derivaadid ja nende terapeutiline kasutamine |